clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
Mystery of What Accelerates Osteosarcoma Development Uncovered
Molecular Dx
Stroke Prediction Boosted By Retinal Imaging
News & Features
New AI-Based Tool Better Matches Patients to Cancer Trials
News & Features
Researchers Discover Unique Skeletal Tissue with Potential for Regenerative Medicine
News & Features
Timberlyne Therapeutics Launched Last Week with a $180 Million Series A…
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
Parkinson’s Disease Genetics Analyzed in Large Study
Centogene
Molecular Dx
Parkinson’s Disease Genetics Analyzed in Large Study
August 2, 2024
0
Molecular Dx
Michael J. Fox Foundation Collaborates with Centogene to Confirm Parkinson’s Risk Factors
January 23, 2024
0
Molecular Dx
New FDA Committee on Genetic Metabolic Diseases Could Boost Field
December 14, 2023
0
News & Features
Insilico Medicine’s AI-Designed Fibrosis Drug Passes Phase I Hurdle
January 10, 2023
0
Informatics
Centogene, Premier Research Partner to Offer Rare Disease Clinical Development Services
January 9, 2023
0
News & Features
Centogene Partners Insilico Medicine to Target Rare Neurometabolic Disease
January 20, 2022
0
News & Features
Can You Rewrite the Future of Rare Diseases With Multiomics?
December 1, 2021
0
News & Features
Centogene and Agios Expand Rare Blood Disease Partnership
November 5, 2021
0
Molecular Dx
Twist and Centogene Collaborate to Better Diagnose Rare Diseases
October 6, 2021
0
News & Features
Evotec, Centogene Forge Rare Disease Collaboration
August 27, 2018
0
1
2
Page 1 of 2
Related Content
Sensitive Tumor DNA Test Effective at Predicting Lung Cancer Progression
JPM 2025: NVIDIA, Mayo Clinic Partner on AI-Powered Digital Pathology
Questions Raised over Opioid Use Disorder Algorithm
New Test Predicts Survival in Early-Stage Lung Cancer Better than Current Methods
Inside Precision Medicine